1. Home
  2. CAAS vs MSLE Comparison

CAAS vs MSLE Comparison

Compare CAAS & MSLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CAAS

China Automotive Systems Inc.

HOLD

Current Price

$4.35

Market Cap

134.9M

ML Signal

HOLD

Logo Satellos Bioscience Inc. Common Stock

MSLE

Satellos Bioscience Inc. Common Stock

N/A

Current Price

$9.78

Market Cap

154.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CAAS
MSLE
Founded
N/A
N/A
Country
China
Canada
Employees
N/A
21
Industry
Auto Parts:O.E.M.
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
134.9M
154.6M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
CAAS
MSLE
Price
$4.35
$9.78
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
10.4K
97.8K
Earning Date
04-22-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.87
$5.44
52 Week High
$5.15
$13.39

Technical Indicators

Market Signals
Indicator
CAAS
MSLE
Relative Strength Index (RSI) 48.75 66.72
Support Level $4.33 $6.71
Resistance Level $4.50 $13.39
Average True Range (ATR) 0.11 0.82
MACD 0.01 0.07
Stochastic Oscillator 57.89 73.42

Price Performance

Historical Comparison
CAAS
MSLE

About CAAS China Automotive Systems Inc.

China Automotive Systems Inc is a holding company. The firm, through its subsidiary, is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series of power steering models, including rack and pinion power steering, integral power steering, electronic power steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.

About MSLE Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.

Share on Social Networks: